Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.10.0.1
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
6 Months Ended
Sep. 30, 2018
USD ($)
$ / shares
shares
Common stock activity  
Beginning balance, outstanding 5,758,970
Preferred Stock Series C Conversion, shares 67,587,868 [1]
Preferred Stock Series B Dividends, shares 3,502
Preferred Stock Series B Dividends, value | $ $ 2,183
Preferred Stock Series B Dividends, per share | $ / shares $ 0.62
Warrants - Abeyance, shares 308,411 [2]
Issuance of Common Stock for settlement of consulting agreement, shares 50,000
Issuance of Common Stock of Prior Conversion of Convertible Notes, shares 141,982
Ending balance, outstanding 73,850,733
[1] Net proceeds or fair value on grant date, as applicable.
[2] Shares previously held in abeyance until such time as it would not result in the investor exceeding its beneficial ownership limitation (4.99% of the Company's outstanding common stock).